Please use this identifier to cite or link to this item:
|Title:||Risk of transfusion-transmitted malaria: evaluation of commercial ELISA kits for the detection of anti-Plasmodium antibodies in candidate blood donors||Authors:||Mangano, Valentina D
|Keywords:||ELISA;IFAT;Plasmodium;Transfusion transmitted malaria||Keywords Plus:||INFECTIONS;GUIDELINES;KNOWLESI;ASSAY||Mesh headings:||Blood Donors;Enzyme-Linked Immunosorbent Assay;Malaria;Mass Screening;Plasmodium||Secondary Mesh headings:||Italy;Retrospective Studies;Sensitivity and Specificity||Issue Date:||22-Jan-2019||Publisher:||BMC||Journal:||Malaria journal||Abstract:||
Transfusion with Plasmodium-infected blood represents a risk for malaria transmission, a rare but severe event. Several non-endemic countries implement a strategy for the screening of candidate blood donors including questionnaire for the identification of at-risk subjects and laboratory testing of blood samples, often serology-based, with temporary deferral from donation for individuals with a positive result. In Italy, the most recent legislation, issued in November 2015, introduced the use of serological tests for the detection of anti-Plasmodium antibodies.
|Appears in Collections:||Articles|
Show full item record
checked on May 3, 2021
checked on Aug 31, 2020
WEB OF SCIENCETM
checked on Nov 26, 2021
Page view(s) 52
checked on Nov 29, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.